scispace - formally typeset
W

Willem Oosterlinck

Researcher at Ghent University

Publications -  37
Citations -  4805

Willem Oosterlinck is an academic researcher from Ghent University. The author has contributed to research in topics: Bladder cancer & Transitional cell carcinoma. The author has an hindex of 16, co-authored 37 publications receiving 4383 citations. Previous affiliations of Willem Oosterlinck include Ghent University Hospital.

Papers
More filters
Journal ArticleDOI

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

TL;DR: These probabilities allow urologists to easily calculate a superficial bladder cancer patient's short- and long-term risks of recurrence and progression after transurethral resection to determine the most appropriate treatment and frequency of follow-up.
Journal ArticleDOI

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

TL;DR: These abridged EAU guidelines present updated information on the diagnosis and treatment of NMIBC for incorporation into clinical practice and the stratification of patients into low, intermediate, and high-risk groups is pivotal to recommending adjuvant treatment.
Journal ArticleDOI

European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.

TL;DR: New guidelines for urothelial cell carcinoma of the upper urinary tract have been prepared to aid clinicians in assessing the current evidence-based management of UUT-UCC and to incorporate present recommendations into daily clinical practice.
Journal ArticleDOI

Factors affecting recurrence and progression in superficial bladder-tumours.

TL;DR: In this paper, a multivariate analysis based on Cox's proportional hazards regression model was performed on the most important prognostic factors and their association with invasion and death, an index was computed reflecting the risk of both invasion and malignant disease, respectively.
Journal ArticleDOI

[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

TL;DR: The 2011 European Association of Urology (EAU) guidelines on non-muscle-invasive bladder cancer (NMIBC) were presented in this paper, and the level of evidence and grade of recommendation were assigned.